Viatris makes and sells generic, branded and newer medicines for patients around the world. It last closed at $20.45 on Nov 17, down 1.40% on the day. The average 12-month price target from 7 analysts is $22.14 (+8.3% from the last close), with a high of $26.00 and a low of $14.00. Analyst consensus is Buy, based on the latest ratings from 7 firms (4 buy, 3 hold, 0 sell). In the past 30 days there were 8 dark pool prints totaling $16.6M, the largest $5.1M.
Each firm's latest rating on VTRS in the past 90 days
Average 12-month target
$22.14
▲ 8.3% upside
Based on 7 analysts who set a price target on VTRS in the past 90 days. The average target is $22.14, with a high of $26.00 and a low of $14.00, compared with the last close of $20.45.
Low $14.00Avg $22.14High $26.00
Blue marker: last close $20.45
Highest target$26.00
Average target$22.14
Lowest target$14.00
Latest rating changes
Leerink PartnersTarget raised
Nov 17Buy$20 → $24
BarclaysTarget raised
Nov 16Buy$22 → $25
JP MorganTarget raised
Nov 7Hold$20 → $21
Piper SandlerTarget raised
Oct 26Hold$13 → $14
JP MorganMaintained
Oct 21Hold$20
Date
Firm
Action
Rating
Price target
Nov 17
Leerink Partners
Target raised
Buy
$20 → $24
Nov 16
Barclays
Target raised
Buy
$22 → $25
Nov 7
JP Morgan
Target raised
Hold
$20 → $21
Oct 26
Piper Sandler
Target raised
Hold
$13 → $14
Oct 21
JP Morgan
Maintained
Hold
$20
Loading…
Technical Analysis
VTRS · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 5% above its 20 day and 11% above its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 64), near overbought. The nearest support is the Pivot S1 at $20.34, and the nearest resistance the Pivot at $20.51.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 2.6%/day
Key levels
$21.2052 week high+3.7%
$21.20Swing high (Nov 12)+3.7%
$20.62Pivot R1+0.8%
$20.51Pivot+0.3%
$20.45Last close
$20.34Pivot S1−0.5%
$19.4920 day average−4.7%
$18.64Swing low (Nov 3)−8.9%
$18.2650 day average−10.7%
$17.52100 day average−14.3%
$16.31200 day average−20.2%
$10.1552 week low−50.4%
Indicators
RSI (14)
64.04
Strong, overbought above 70
Neutral
MACD
0.76
Above its signal line
Bullish
Stochastic
80.5
Near the top of its range
Overbought
ADX (14)
36.9
Trending up
Williams %R
-29.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
81.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+8.1%
Change over 10 sessions
Bullish
ATR (14)
$0.53
Typical daily range, 2.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityNormal, 5.3%/day
Key levels
$21.2052 week high+3.7%
$21.20Swing high (Nov 12)+3.7%
$20.62Pivot R1+0.8%
$20.51Pivot+0.3%
$20.45Last close
$20.34Pivot S1−0.5%
$19.4920 day average−4.7%
$18.64Swing low (Nov 3)−8.9%
$18.2650 day average−10.7%
$17.52100 day average−14.3%
$16.31200 day average−20.2%
$10.1552 week low−50.4%
Indicators
RSI (14)
70.18
Overbought above 70
Overbought
MACD
1.24
Above its signal line
Bullish
Stochastic
92.4
Near the top of its range
Overbought
ADX (14)
38.9
Trending up
Williams %R
-14.4
Oversold below −80, overbought above −20
Overbought
CCI (20)
193.9
Oversold below −100, overbought above 100
Overbought
Rate of change
+23.9%
Change over 10 sessions
Bullish
ATR (14)
$1.09
Typical daily range, 5.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for VTRS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VTRS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow VTRS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VTRS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTRS is in one of them and how their past VTRS trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Viatris
Viatris is a healthcare company based in Canonsburg, Pennsylvania, that makes and sells medicines for patients around the world. Its portfolio includes generic medicines, including complex products, familiar branded medicines, and newer medicines it is developing. It runs manufacturing, packaging and distribution sites worldwide and serves patients and other customers in many countries.